Prevalence of hepatitis C virus among users attending a voluntary testing centre in Rio Grande, southern Brazil: Predictive factors and hepatitis C virus genotypes

International Journal of STD and AIDS

Volumn 21, Issue 7, 2010, Pages 466-471

  Germano, F N ^a   Dos Santos, C A ^a   Honscha, G ^b   Strasburg, A ^a   Gabbi, B ^a   Mendoza Sassi, R A ^a   Soares, E A ^c   Seuanez H N ^c   Soares, M A ^c   Martinez A M B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b Laboratório Municipal de Análises Clínicas de Rio Grande   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Genotype; HCV; Prevalence; Risk factors; Southern Brazil

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BRAZIL; DNA SEQUENCE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEXUAL COUNSELING; VIRUS GENOME; VIRUS TRANSMISSION;

5' UNTRANSLATED REGIONS; ADULT; BRAZIL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; PREVALENCE; RISK FACTORS; RNA, VIRAL;

EID: 77957746466     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009089     Document Type: Article

References (41)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67 (Pubitemid 41196755)
2. Moghaddam SM, Alavian SM, Kermani NA. Hepatitis C and renal transplantation: a review on historical aspects and current issues. Rev Med Virol 2008;18:375-86
3. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002;19:1-46
4. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:41-6
5. Aquino JA, Pegado KA, Barros LP, Machado LF. Seroprevalence of hepatitis B virus and hepatitis C virus infections among individuals in the State of Para. Rev Soc Bras Med Trop 2008;41:334-7
6. Fagundes GD, Bonazza V, Ceretta LB, Back AJ, Bettiol J. Detection of the Hepatitis C virus in a population of adults. Rev Lat Am Enfermagem 2008;16:396-400
7. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 2008;80:53-7
8. Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 2009;510:33-53
9. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007;38:606-11
10. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36:S65-73
11. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005;10:1-11 (Pubitemid 40767627)
12. Metzger D, Dephilippis D, Druley P. The impact of HIV testing on risk for AIDS behaviors. In: Harris LS, ed. Problems of Drug Dependence. Washington DC: National Institute on Drug Abuse, 1992:297-8
13. Pechansky F, Metzger D, Hirakata V. Adaptação e validação de um questionário sobre comportamento de risco para AIDS em usuários de drogas em Porto Alegre. Rev Bras Psiquiatr 2002;24:130-6
14. Campiotto S, Pinho JR, Carrilho FJ, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005;38:41-9 (Pubitemid 40277937)
15. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-8
16. Victora CH, Fuchs S, Olinto S MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 1997;26:224-7 (Pubitemid 27129589)
17. STATA. Stata Statistical Software: Release 9.2. College Station, TX: Stata Corp LP, 2006
18. Germano FN, da Silva TM, Mendoza-Sassi R, Martinez AM. High prevalence of users who did not return to the testing and counseling center (TCC) for knowing their serological status: Rio Grande, RS, Brazil. Cien Saude Colet 2008;13:1033-40
19. Ministério da Sańde Brasileiro. Hepatites Virais. Secretaria de Vigilância em Saúde. Brasília, 2005
20. Moraes E, Honscha G, Silva PEA, et al. Estudo sorológico das hepatites B e C na cidade do Rio Grande no período 2002-2005. Braz J Infect Dis 2005;9:S43
21. Mal A, Aar S, Mar D. Hepatites B e C em usuários do Centro de Testagem e Aconselhamento (CTA) de Fortaleza-Ceará. DST - J Bras Doenças Sex Transm 2006;18:161-7
22. Yee LJ, Weiss HL, Langner RG, et al. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis 2001;1:8
23. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16 (Pubitemid 30421405)
24. Brown RS Jr., Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl 2003;9:S10-3
25. Brandao AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol 2002;2:18
26. Khaja MN, Madhavi C, Thippavazzula R, et al. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 2006;6:198-204
27. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-41
28. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008;48:148-62 (Pubitemid 350191999)
29. Caiaffa WT, Proietti FA, Carneiro-Proietti AB, et al. The dynamics of the human immunodeficiency virus epidemics in the south of Brazil: increasing role of injection drug users. Clin Infect Dis 2003;37 (Suppl. 5):S376-81
30. Marchesini AM, Pra-Baldi ZP, Mesquita F, Bueno R, Buchalla CM. Hepatitis B and C among injecting drug users living with HIV in Sao Paulo, Brazil. Rev Saude Publ 2007;41(Suppl. 2):57-63
31. Oliveira ML, Yoshida CF, Telles PR, et al. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect 2009;137:970-9
32. de Andrade SM, Tamaki EM, Vinha JM, et al. Vulnerability of men who have sex with men in the context of AIDS. Cad Saude Publica 2007;23:479-82
33. Carret ML, Fassa AG, da Silveira DS, Bertoldi AD, Hallal PC. Sexually transmitted diseases symptoms in adults: prevalence and risk factors. Rev Saude Publ 2004;38:76-84 (Pubitemid 38139507)
34. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006;3:35-40
35. Lavillette D, Morice Y, Germanidis G, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005;79:6023-34 (Pubitemid 40617208)
36. Sandres-Saune K, Deny P, Pasquier C, et al. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003;109:187-93 (Pubitemid 36507107)
37. Cantaloube JF, Laperche S, Gallian P, et al. Analysis of the 5(noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 2006;44:2051-6
38. Hraber PT, Fischer W, Bruno WJ, Leitner T, Kuiken C. Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: the 5(untranslated region (UTR) fails to classify subtypes. Virol J 2006;3:103 (Pubitemid 46091621)
39. Tamalet C, Colson P, Tissot-Dupont H, et al. Genomic and phylogenetic analysis of hepatitis C virus isolates: a survey of 535 strains circulating in southern France. J Med Virol 2003;71:391-8 (Pubitemid 37176628)
40. Vigani AG, Pavan MH, Tozzo R, et al. Comparative study of patients with chronic hepatitis C virus infection due to genotypes 1 and 3 referred for treatment in southeast Brazil. BMC Infect Dis 2008;8:164
41. Krug LP, Lunge VR, Ikuta N, et al. Hepatitis C virus genotypes in Southern Brazil. Braz J Med Biol Res 1996;29:1629-32 (Pubitemid 126485412)